Access to cannabis flower treatments gains new momentum in Brazil with judicial safe conduct support

Recent data from the "Insights and Opportunities Report of the 4th Edition of the Medical Cannabis Fair" - in 2026 the event will be renamed Cannabis Fair - produced by the Sechat portal, indicates that pain is the main motivation for seeking cannabinoid therapy in Brazil.

The survey, conducted with over 1,200 doctors during the main business fair in Latin America, reveals that among the 72.59% of professionals who already prescribe the substance, the predominant treatments are aimed at pain (22.52%), sleep induction (18.81%), and mood disorders (17.20%).

In light of this growing demand for therapies for pain and chronic conditions, such as epilepsy, Cannect and the Pauloafonsina Association of Cannabis Studies (ASPAEC) have formalized a strategic partnership. The goal is to connect doctors and patients to treatments that use medicinal cannabis flowers (in natura) within the national territory, filling a gap left by recent regulatory restrictions.

Legal Security and the Safe Conduct

The differential of this operation lies in its legal basis. Although the National Health Surveillance Agency (Anvisa) has suspended the individual importation of cannabis flowers, patient associations like ASPAEC operate under the protection of judicial safe conducts. These decisions allow for the cultivation, production, and distribution of genetics adapted to Brazil, ensuring the regulatory compliance of the partnership.

For ASPAEC president Caroline Rose Barros Nunes, this judicial authorization is essential for adherence to treatment. "The safe conduct represents legal security for the patient. It guarantees peace of mind to use and transport their medication legally, avoiding risks and allowing treatment to proceed as prescribed by the doctor," says Nunes.

According to the executive, the profile of the patient seeking flowers generally involves the need for rapid therapeutic responses and refined symptom control, opting for a "natural, personalized, and effective therapeutic alternative."

Medical Criteria and Market Expansion

ASPAEC operates without a limit on the number of members but maintains a case-by-case evaluation process for new admissions. The partnership reinforces that medicinal use — both of the flower and oils and derivatives — requires rigorous professional monitoring and transparency about risks and benefits. "At ASPAEC, the reception has been designed to be simple, humane, and fully assisted," explains Nunes.

For Allan Paiotti, CEO of Cannect, the reintroduction of flowers into the company's portfolio follows a market and holistic health logic, projecting a quick recovery of the market share that this format occupied before the import restrictions.

"This recovery is the natural evolution of our integral care thesis. We maintain a rigorous medical criterion, guidance for strictly medicinal use, and total transparency about benefits and risks. Flowers represented 30% of the market in 2023, before Anvisa's ban, and our expectation is that they will return to levels of 20% to 30% in less than a year," projects Paiotti.

Follow the Sechat Portal interview with Allan Paiotti, CEO of Cannect: 

Logistics and Infrastructure

The joint operation promises to unite Cannect's technological reach with the production capacity of the Association. According to Nunes, the partnership has brought "a very positive synergy," based on continuous monitoring and patient feedback for quick process adjustments.

On the production side, the Association has structured its operation to gain scale without losing sanitary standards, seeking laboratory and pharmaceutical quality levels. Dispensation is carried out directly by the Association to the patient, ensuring end-to-end traceability.

In logistical terms, the patient has delivery options through three partner companies, with an average delivery time of four business days for the Southeast and nationwide coverage. The flowers are sent in sealed packaging with humidity controllers. "Today we are already 100% operational and prepared to meet both the current demand and the growth that will come," assures ASPAEC.